| Name | Sheriden Woods |
|---|---|
| Location | 321 Stonecrest Drive, Bristol, Connecticut |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 146 |
| Occupancy Rate | 80.27% |
| Medicare ID (CCN) | 075350 |
| Legal Business Name | Sheriden Woods Health Care Center Inc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1194168591 |
| Organization Name | SHERIDEN WOODS HEALTH CARE CENTER, INC. |
| Doing Business As | SHERIDEN WOODS HEALTH CARE CENTER |
| Address | 321 Stonecrest Dr, Bristol, CT 06010 |
| Phone Number | 860-583-1827 |
News Archive
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
A new study by researchers at NYU Langone Medical Center found a high desire for additional genetic testing among consumers for life altering and threatening medical conditions including mental retardation, blindness, deafness, cancer, heart disease, dwarfism and shortened lifespan from death by 5 years of age.
The most recent edition of the authoritative Tobacco Atlas, released by the American Cancer Society and World Lung Foundation, ranks nations on their success in combating illegal sales of cigarettes and tobacco products.
Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, for the management of acute moderate-to-severe pain in adults.
› Verified 3 days ago
| NPI Number | 1841383403 |
| Organization Name | SHERIDEN WOODS HEALTH CARE CENTER INC |
| Doing Business As | SHERIDEN WOODS HEALTH CARE CENTER |
| Address | 321 Stonecrest Drive, Bristol, CT 06010 |
| Phone Number | 860-583-1827 |
News Archive
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
A new study by researchers at NYU Langone Medical Center found a high desire for additional genetic testing among consumers for life altering and threatening medical conditions including mental retardation, blindness, deafness, cancer, heart disease, dwarfism and shortened lifespan from death by 5 years of age.
The most recent edition of the authoritative Tobacco Atlas, released by the American Cancer Society and World Lung Foundation, ranks nations on their success in combating illegal sales of cigarettes and tobacco products.
Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, for the management of acute moderate-to-severe pain in adults.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
A new study by researchers at NYU Langone Medical Center found a high desire for additional genetic testing among consumers for life altering and threatening medical conditions including mental retardation, blindness, deafness, cancer, heart disease, dwarfism and shortened lifespan from death by 5 years of age.
The most recent edition of the authoritative Tobacco Atlas, released by the American Cancer Society and World Lung Foundation, ranks nations on their success in combating illegal sales of cigarettes and tobacco products.
Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, for the management of acute moderate-to-severe pain in adults.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 19.88 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.69 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 43.45 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.57 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.59 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 2.49 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 7.03 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 89.84 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 19.03 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 43.19 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.56 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 27.65 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 33.81 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 6.46 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.97 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 67.32 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 75.93 | 82.93 |
News Archive
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
A new study by researchers at NYU Langone Medical Center found a high desire for additional genetic testing among consumers for life altering and threatening medical conditions including mental retardation, blindness, deafness, cancer, heart disease, dwarfism and shortened lifespan from death by 5 years of age.
The most recent edition of the authoritative Tobacco Atlas, released by the American Cancer Society and World Lung Foundation, ranks nations on their success in combating illegal sales of cigarettes and tobacco products.
Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, for the management of acute moderate-to-severe pain in adults.
› Verified 3 days ago
Pines At Bristol For Nursing & Rehabilitation, The Location: 61 Bellevue Avenue, Bristol, Connecticut 06010 Phone: (860) 589-1682 | |
Countryside Manor Of Bristol Location: 1660 Stafford Avenue, Bristol, Connecticut 06010 Phone: (860) 583-8483 |